236 related articles for article (PubMed ID: 24702741)
1. Prognostic models predicting survival of patients with brain metastases: integration of lactate dehydrogenase, albumin and extracranial organ involvement.
Nieder C; Marienhagen K; Dalhaug A; Aandahl G; Haukland E; Pawinski A
Clin Oncol (R Coll Radiol); 2014 Aug; 26(8):447-52. PubMed ID: 24702741
[TBL] [Abstract][Full Text] [Related]
2. Karnofsky performance status and lactate dehydrogenase predict the benefit of palliative whole-brain irradiation in patients with advanced intra- and extracranial metastases from malignant melanoma.
Partl R; Richtig E; Avian A; Berghold A; Kapp KS
Int J Radiat Oncol Biol Phys; 2013 Mar; 85(3):662-6. PubMed ID: 22901382
[TBL] [Abstract][Full Text] [Related]
3. Prediction of short survival in patients with brain metastases based on three different scores: a role for 'triple-negative' status?
Nieder C; Pawinski A; Molls M
Clin Oncol (R Coll Radiol); 2010 Feb; 22(1):65-9. PubMed ID: 19762219
[TBL] [Abstract][Full Text] [Related]
4. External validation of a prognostic score predicting overall survival for patients with brain metastases based on extracranial factors.
Lewitzki V; Klement RJ; Hess S; Kosmala R; Nieder C; Flentje M
Clin Transl Radiat Oncol; 2019 May; 16():15-20. PubMed ID: 30906886
[TBL] [Abstract][Full Text] [Related]
5. External Validation of a Prognostic Score for Patients with Brain Metastases: Extended Diagnosis-Specific Graded Prognostic Assessment.
Nieder C; Hess S; Lewitzki V
Oncol Res Treat; 2020; 43(5):221-227. PubMed ID: 32213772
[TBL] [Abstract][Full Text] [Related]
6. Prognostic indexes for brain metastases: which is the most powerful?
Viani GA; da Silva LG; Stefano EJ
Int J Radiat Oncol Biol Phys; 2012 Jul; 83(3):e325-30. PubMed ID: 22633551
[TBL] [Abstract][Full Text] [Related]
7. The number of involved extracranial organs: a new predictor of survival in breast cancer patients with brain metastasis.
Gerdan L; Segedin B; Nagy V; Khoa MT; Trang NT; Schild SE; Rades D
Clin Neurol Neurosurg; 2013 Oct; 115(10):2108-10. PubMed ID: 23954201
[TBL] [Abstract][Full Text] [Related]
8. Recursive partitioning analysis (RPA) class does not predict survival in patients with four or more brain metastases.
Nieder C; Andratschke N; Grosu AL; Molls M
Strahlenther Onkol; 2003 Jan; 179(1):16-20. PubMed ID: 12540980
[TBL] [Abstract][Full Text] [Related]
9. Towards improved prognostic scores predicting survival in patients with brain metastases: a pilot study of serum lactate dehydrogenase levels.
Nieder C; Marienhagen K; Dalhaug A; Norum J
ScientificWorldJournal; 2012; 2012():609323. PubMed ID: 22593701
[TBL] [Abstract][Full Text] [Related]
10. Institutional, retrospective analysis of 777 patients with brain metastases: treatment outcomes and diagnosis-specific prognostic factors.
Antoni D; Clavier JB; Pop M; Schumacher C; Lefebvre F; Noël G
Int J Radiat Oncol Biol Phys; 2013 Jul; 86(4):630-7. PubMed ID: 23582409
[TBL] [Abstract][Full Text] [Related]
11. A new score predicting survival prognosis after whole-brain radiotherapy alone for brain metastases in elderly patients.
Evers JN; Schild SE; Segedin B; Nagy V; Khoa MT; Trang NT; Rades D
Anticancer Res; 2014 May; 34(5):2455-8. PubMed ID: 24778060
[TBL] [Abstract][Full Text] [Related]
12. Best supportive care in patients with brain metastases and adverse prognostic factors: development of improved decision aids.
Nieder C; Norum J; Dalhaug A; Aandahl G; Engljähringer K
Support Care Cancer; 2013 Oct; 21(10):2671-8. PubMed ID: 23686380
[TBL] [Abstract][Full Text] [Related]
13. Prognostic factors for survival in patients treated with stereotactic radiosurgery for recurrent brain metastases after prior whole brain radiotherapy.
Caballero JA; Sneed PK; Lamborn KR; Ma L; Denduluri S; Nakamura JL; Barani IJ; McDermott MW
Int J Radiat Oncol Biol Phys; 2012 May; 83(1):303-9. PubMed ID: 22079723
[TBL] [Abstract][Full Text] [Related]
14. A new scoring system to predicting the survival of patients treated with whole-brain radiotherapy for brain metastases.
Rades D; Dunst J; Schild SE
Strahlenther Onkol; 2008 May; 184(5):251-5. PubMed ID: 18427755
[TBL] [Abstract][Full Text] [Related]
15. Whole-brain radiotherapy with 20 Gy in 5 fractions for brain metastases in patients with cancer of unknown primary (CUP).
Rades D; Bohlen G; Lohynska R; Veninga T; Stalpers LJ; Schild SE; Dunst J
Strahlenther Onkol; 2007 Nov; 183(11):631-6. PubMed ID: 17960339
[TBL] [Abstract][Full Text] [Related]
16. Tumor marker analyses in patients with brain metastases: patterns of practice and implications for survival prediction research.
Nieder C; Dalhaug A; Haukland E; Mannsåker B; Pawinski A
Tumour Biol; 2015 Aug; 36(8):6471-6. PubMed ID: 25801247
[TBL] [Abstract][Full Text] [Related]
17. KPS/LDH index: a simple tool for identifying patients with metastatic melanoma who are unlikely to benefit from palliative whole brain radiotherapy.
Partl R; Fastner G; Kaiser J; Kronhuber E; Cetin-Strohmer K; Steffal C; Böhmer-Breitfelder B; Mayer J; Avian A; Berghold A
Support Care Cancer; 2016 Feb; 24(2):523-528. PubMed ID: 26105515
[TBL] [Abstract][Full Text] [Related]
18. Radiosurgery for brain metastases from primary lung carcinoma.
Hoffman R; Sneed PK; McDermott MW; Chang S; Lamborn KR; Park E; Wara WM; Larson DA
Cancer J; 2001; 7(2):121-31. PubMed ID: 11324765
[TBL] [Abstract][Full Text] [Related]
19. A validation study of a new prognostic index for patients with brain metastases: the Graded Prognostic Assessment.
Sperduto CM; Watanabe Y; Mullan J; Hood T; Dyste G; Watts C; Bender GP; Sperduto P
J Neurosurg; 2008 Dec; 109 Suppl():87-9. PubMed ID: 19123893
[TBL] [Abstract][Full Text] [Related]
20. Stereotactic radiosurgery alone versus resection plus whole-brain radiotherapy for 1 or 2 brain metastases in recursive partitioning analysis class 1 and 2 patients.
Rades D; Bohlen G; Pluemer A; Veninga T; Hanssens P; Dunst J; Schild SE
Cancer; 2007 Jun; 109(12):2515-21. PubMed ID: 17487853
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
